Trial Profile
A trial to detect alpha-fetoprotein as a tumor marker for hepatocellular carcinoma in chronic hepatitis B patients receiving entecavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 23 Dec 2015 New trial record